Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Tang, Kevin. Director active across 1 company, notably Aurinia Pharmaceuticals Inc.. Aggregated, 15 disclosures have been logged. Breakdown: 10 buys · 0 sell. Total volume traded: €7.7m. Activity tracked since 29 May 2026. The latest transaction was filed on 2 June 2026 (70 - Acquisition or disposition (writing) of third party derivative). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Tang, Kevin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2,299 shares@ CA$15.350.0010% mcap0.3% of flowCommon SharesTSXSEDI:4728128
Canonical exit: 27 Aug 2026 (T+90)
15 of 15 declarations
About Tang, Kevin
Tang, Kevin is an insider at Aurinia Pharmaceuticals Inc. (XNAS), where he is 4 - Director of Issuer, 5 - Senior Officer of Issuer. He has 15 filings in total, and across the sampled recent filings there were buys totaling EUR 7747370, with no sales, over the period from 2026-06-03 to 2026-06-03.